Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Enzo Biochem Inc.

    NYSE: ENZ · Real-Time Price · USD
    0.31
    -0.07 (-18.76%)
    At close: Apr 17, 2025, 3:59 PM

    Enzo Biochem Statistics

    Share Statistics

    Enzo Biochem has 52.4M shares outstanding. The number of shares has increased by 1.84% in one year.

    Shares Outstanding

    n/a
    		 52.4M

    Shares Change (YoY)

    n/a
    		 1.84%

    Shares Change (QoQ)

    n/a
    		 0.3%

    Owned by Institutions (%)

    n/a
    		 26.26%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 7,843

    FTD / Avg. Volume

    n/a
    		 2.26%

    Short Selling Information

    The latest short interest is 364.9K, so 0.7% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 364.9K

    Short % of Shares Out

    n/a
    		 0.7%

    Short % of Float

    n/a
    		 0.78%

    Short Ratio (days to cover)

    n/a
    		 2

    Valuation Ratios

    The PE ratio is -2.23 and the forward PE ratio is -4.48. Enzo Biochem's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 -2.23

    Forward PE

    n/a
    		 -4.48

    PS Ratio

    n/a
    		 1.82

    Forward PS

    n/a
    		 0.2

    PB Ratio

    n/a
    		 1.03

    P/FCF Ratio

    n/a
    		 -2.16

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Enzo Biochem.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.06.

    Current Ratio

    n/a
    		 2.82

    Quick Ratio

    n/a
    		 2.55

    Debt / Equity

    n/a
    		 0.06

    Debt / EBITDA

    n/a
    		 -0.42

    Debt / FCF

    n/a
    		 -0.13

    Interest Coverage

    n/a
    		 -49.83

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $255,256

    Profits Per Employee

    n/a
    		 $-208,624

    Employee Count

    n/a
    		 125

    Asset Turnover

    n/a
    		 0.37

    Inventory Turnover

    n/a
    		 2.53

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -70.48% in the last 52 weeks. The beta is 1.16, so Enzo Biochem's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.16

    52-Week Price Change

    n/a
    		 -70.48%

    50-Day Moving Average

    n/a
    		 0.44

    200-Day Moving Average

    n/a
    		 0.86

    Relative Strength Index (RSI)

    n/a
    		 51.84

    Average Volume (20 Days)

    n/a
    		 346,664

    Income Statement

    In the last 12 months, Enzo Biochem had revenue of 31.91M and earned -26.08M in profits. Earnings per share was -0.51.

    Revenue

    n/a
    		 31.91M

    Gross Profit

    n/a
    		 14.63M

    Operating Income

    n/a
    		 -9.82M

    Net Income

    n/a
    		 -26.08M

    EBITDA

    n/a
    		 -8.35M

    EBIT

    n/a
    		 -9.62M

    Earnings Per Share (EPS)

    n/a
    		 -0.51
    Full Income Statement

    Balance Sheet

    The company has 52.37M in cash and 3.51M in debt, giving a net cash position of 48.86M.

    Cash & Cash Equivalents

    n/a
    		 52.37M

    Total Debt

    n/a
    		 3.51M

    Net Cash

    n/a
    		 48.86M

    Retained Earnings

    n/a
    		 -294.43M

    Total Assets

    n/a
    		 67.51M

    Working Capital

    n/a
    		 35.04M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -26.26M and capital expenditures -545K, giving a free cash flow of -26.8M.

    Operating Cash Flow

    n/a
    		 -26.26M

    Capital Expenditures

    n/a
    		 -545K

    Free Cash Flow

    n/a
    		 -26.8M

    FCF Per Share

    n/a
    		 -0.53
    Full Cash Flow Statement

    Margins

    Gross margin is 45.86%, with operating and profit margins of -30.77% and -81.73%.

    Gross Margin

    n/a
    		 45.86%

    Operating Margin

    n/a
    		 -30.77%

    Pretax Margin

    n/a
    		 -30.77%

    Profit Margin

    n/a
    		 -81.73%

    EBITDA Margin

    n/a
    		 -26.16%

    EBIT Margin

    n/a
    		 -30.77%

    FCF Margin

    n/a
    		 -84.01%

    Dividends & Yields

    ENZ does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ENZ.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 21, 2004. It was a forward split with a ratio of 21:20.

    Last Split Date

    n/a
    		 Oct 21, 2004

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 21:20

    Scores

    Altman Z-Score

    n/a
    		 -5.11

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist